Author

Dipali Dhawan

Lab Director, PanGenomics International Pvt. Ltd., Ahmedabad - Cited by 307 - Cancer stem cells - pharmacogenomics - induced pluripotent stem cells

Biography

Dr Dipali Dhawan is working as a Lab Director PanGenomics International Private Ltd. Previously worked as Team Leader Xcelris Labs Ltd. from 2015-2016. Completed Doctor of Philosophy (Ph.D.), Biotechnology in Nirma University Gujarat, India
Title
Cited by
Year
Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma
D Dhawan, FC Hamdy, I Rehman, J Patterson, SS Cross, KM Feeley, ...The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006200
92
2006
OMICS: biomedical perspectives and applications
D BarhCRC Press, 201139201
39
2011
Cancer biomarkers: minimal and noninvasive early diagnosis and prognosis
D Barh, A Carpi, M Verma, M GunduzCRC Press, 2014201
27
2014
Genetic variability & chemotoxicity of 5-fluorouracil & cisplatin in head & neck cancer patients: a preliminary study
D Dhawan, H Panchal, S Shukla, H PadhThe Indian journal of medical research 137 (1), 125, 2013201
24
2013
Pharmacogenetics: technologies to detect copy number variations.
D Dhawan, H PadhCurrent Opinion in Molecular Therapeutics 11 (6), 670-680, 2009200
22
2009
Genetic variations in TCF7L2 influence therapeutic response to sulfonylureas in Indian diabetics
D Dhawan, H PadhDiabetes Research and Clinical Practice 121, 35-40, 2016201
18
2016
Omics approaches in breast cancer
D BarhSpringer, India, Private, 2016201
18
2016
Prenatal screening for co-inheritance of sickle cell anemia and β-thalassemia traits
D Dhawan, S Chaudhary, K Chandratre, A Ghosh, N SojitraClin Med Biochem Open Access 2 (01), 2471-2663.1000108, 2016201
9
2016
Omics for personalized medicine
D Barh, D Dhawan, NK GangulySpringer, 2013201
9
2013
Compound heterozygous β+ β0 mutation of HBB gene leading to β-thalassemia major in a Gujarati family—A case study
S Chaudhary, D Dhawan, PG Bagali, PS Chaudhary, A Chaudhary, ...Molecular genetics and metabolism reports 7, 51-53, 2016201
8
2016
Whole gene sequencing based screening approach to detect β-thalassemia mutations
S Chaudhary, D Dhawan, N Sojitra, P Chauhan, K Chandratre, ...Biol Med (Aligarh) 9 (383), 2, 2017201
5
2017
Molecular and cellular therapeutics
D Whitehouse, R RapleyWiley-Blackwell, 2012201
5
2012
Clinical next-generation sequencing: enabling precision medicine
D DhawanProgress and Challenges in Precision Medicine, 35-5, 2017201
4
2017
Whole-genome sequencing of Brevundimonas diminuta XGC1, isolated from a tuberculosis patient in Gujarat, India
A Ghosh, K Chandratre, A Chaudhary, S Chaudhary, N Badani, ...Genome Announcements 3 (3), 10.1128/genomea. 00686-15, 2015201
4
2015
Cancer biomarkers for diagnosis, prognosis and therapy
D Barh, V Agte, D Dhawan, V Agte, H PadhMolecular and Cellular Therapeutics, 18, 2012201
4
2012
Investigating the role of plasma glucose concentration as a phenotypic marker for CYP2C9 genetic variants, in the diabetic population of Gujarat
D Bhatt, N Chauhan, A Sharma, D Dhawan, RV Bhatt, S Phatak, H PadhIndian Journal of Pharmaceutical Sciences 76 (1), 72, 2014201
3
2014
Thymidylate synthase enhancer region: Novel allele in Indians
D Dhawan, H PadhAnnals of human biology 44 (1), 87-90, 2017201
3
2017
Pharmacogenomics and personalized medicine for cancer
D Dhawan, H PadhOmics for personalized medicine, 215-25, 20120
3
2013
Omics approaches in cancer biomarker and targeted anticancer drug discovery
D Dhawan, H PadhOMICS: biomedical perspectives and applications. CRC Press, Taylor & Francis …, 01101
2
2011
Biotechnology for Biomarkers: Towards Prediction, Screening, Diagnosis, Prognosis, and Therapy
D DhawanOmics Technologies and Bio-Engineering, 533-557, 01801
2
2018

Referred From: https://scholar.google.co.in/citations?user=9ceHJQMAAAAJ&hl=en

Cited by
Citations 307
h-index 9
i10-index 7
Recommended Journals
Open Access Journals